Prescription required — we do not proceed without oneSourced through licensed Türkiye pharmacy channelsİTS serial-traceable — verifiable by karekodDelivered in person — not shipped by courierInvoicedWhatsApp: +447429917553

Multiple Myeloma Treatment in Azerbaijan 2026 — Darzalex, Revlimid, Kyprolis

Newly-diagnosed and relapsed/refractory MM — CD38 mAbs, IMiDs and proteasome inhibitors supplied to Baku.

📱 WhatsApp Consultation

Pharmacy Remedy supplies the modern multiple myeloma backbone to Azerbaijan: Daratumumab (Darzalex) anti-CD38, Lenalidomide (Revlimid) IMiD maintenance, and Carfilzomib (Kyprolis) for proteasome inhibition. Triplet and quadruplet regimens supported.

Standard Regimens

Newly-diagnosed transplant-eligible: D-VRd (Darzalex + Velcade + Revlimid + dex) × 4, then ASCT
Newly-diagnosed non-transplant: D-Rd (Darzalex + Revlimid + dex)
Maintenance post-ASCT: Revlimid 10-15 mg daily until progression
Relapsed 2L+: KRd (Kyprolis + Revlimid + dex) or DKd